Complete Filing Data
Pharmagreen Biotech Inc. reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of -$834.5 thousand for FY2019.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Pharmagreen Biotech Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Net Income * | -$875.5K | -$4.5M | -$2.5M | -$767.5K | -$1.1M |
| Operating Expenses | $1.1M | $744.1K | $485.8K | $642.2K | $748.7K |
| General And Administrative Expense | $65.6K | $79.4K | $63.7K | $99.1K | $57.7K |
| Operating Income Loss | -$1.1M | -$744.1K | -$485.8K | -$642.2K | -$748.7K |
| Nonoperating Income Expense | $226.0K | -$3.8M | -$2.0M | -$126.6K | -$324.9K |
| Net Income Loss Attributable To Noncontrolling Interest | -$44.7K | -$1.3K | |||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$2.4M | -$758.4K | -$971.7K | ||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | |||||
| Income Taxes Paid Net | $0.00 | $0.00 | $0.00 | ||
| Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest | |||||
| Other Nonoperating Income Expense | |||||
| Revenues | |||||
| Cost Of Goods And Services Sold |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q2 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$162.9K | -$39.4K | $251.9K | -$1.0M | $18.7K | -$142.2K | -$3.1M | -$417.1K | -$1.4M | -$3.6K | -$206.1K | -$57.3K | -$93.1K | -$392.9K | -$329.1K | |
| Operating Expenses | $82.2K | $120.2K | $181.1K | $241.2K | $458.9K | $203.7K | $232.4K | $136.9K | $86.9K | $150.6K | $117.1K | $58.3K | $93.6K | $205.3K | $328.4K | |
| General And Administrative Expense | -$3.3K | $14.4K | $17.8K | $16.3K | $20.9K | $27.2K | $20.7K | $19.2K | $28.7K | $37.2K | $24.9K | $13.6K | $23.5K | $27.3K | $38.7K | |
| Operating Income Loss | -$188.0K | -$181.1K | -$241.2K | -$1.0M | -$203.7K | -$232.4K | -$136.9K | -$86.9K | -$150.6K | -$117.1K | -$58.3K | -$93.6K | -$205.3K | -$328.4K | ||
| Nonoperating Income Expense | -$576.9K | $90.2K | -$3.0M | -$1.3M | $147.0K | -$88.9K | -$241.00 | -$298.00 | -$187.6K | -$615.00 | ||||||
| Net Income Loss Attributable To Noncontrolling Interest | -$26.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$83.00 | -$44.00 | $8.00 | -$117.00 | -$36.00 | -$457.00 | -$782.00 | |||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$3.2M | -$1.4M | $28.0K | -$218.4K | -$107.0K | -$139.2K | -$294.2K | -$344.8K | ||||||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$30.9K | -$2.4K | -$12.1K | $40.9K | -$17.5K | -$2.5K | -$13.2K | -$12.7K | -$42.5K | -$17.1K | $31.5K | -$12.4K | ||||
| Income Taxes Paid Net | $0.00 | $0.00 | ||||||||||||||
| Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest | -$3.1M | -$417.1K | -$3.6K | -$58.6K | -$3.6K | -$206.1K | -$329.1K | |||||||||
| Other Nonoperating Income Expense | -$80.9K | -$67.7K | $141.7K | $493.2K | -$576.9K | $222.4K | $90.2K | |||||||||
| Revenues | $597.00 | $963.00 | $0.00 | $0.00 | ||||||||||||
| Cost Of Goods And Services Sold | $389.00 | $985.00 | $0.00 | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|
| Stockholders Equity * | -$1.7M | -$2.9M | -$834.5K | -$1.4M | -$2.4M | |
| Cash | $62.7K | |||||
| Retained Earnings Accumulated Deficit | -$11.7M | -$7.2M | -$4.7M | -$4.0M | ||
| Liabilities Current | $2.0M | $3.2M | $1.5M | $1.8M | ||
| Liabilities And Stockholders Equity | $373.1K | $266.2K | $630.3K | $449.4K | ||
| Liabilities | $2.1M | $3.2M | $1.5M | $1.8M | ||
| Common Stock Value | $381.2K | $95.8K | $75.6K | $71.6K | ||
| Assets | $373.1K | $266.2K | $630.3K | $449.4K | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$8.4K | $36.7K | $47.8K | $38.7K | ||
| Accounts Payable And Accrued Liabilities Current | $659.4K | $539.7K | $855.8K | $624.7K | ||
| Minority Interest | -$46.7K | -$46.5K | -$1.3K | |||
| Convertible Notes Payable Current | $190.8K | $641.1K | $75.1K | |||
| Convertible Long Term Notes Payable | $0.00 | $7.8K | $3.4K | $1.6K | $693.00 | |
| Prepaid Expense And Other Assets | $200.6K | $347.5K | $253.8K | $115.9K | $14.5K | |
| Accretion Amortization Of Discounts And Premiums Investments | -$18.5K | -$88.3K | -$328.3K | |||
| Accounts And Other Receivables Net Current | $383.00 | $290.00 | $295.00 | $10.6K | $31.8K | |
| Interest And Debt Expense | $28.8K | $680.7K | $343.9K | |||
| Assets Current | $189.2K | $198.1K | ||||
| Debt Instrument Unamortized Discount Noncurrent | $0.00 | $19.2K | $23.6K | $27.3K | ||
| Preferred Stock Value | $10.00 | $0.00 | ||||
| Cash And Cash Equivalents Period Increase Decrease | -$50.5K | -$89.2K | $135.4K | |||
| Gain Loss On Disposition Of Intangible Assets | $215.6K | -$3.3M | $1.1M | -$331.5K | ||
| Gain Loss On Sale Of Debt Investments | $0.00 | $237.9K | -$33.1K | |||
| Derivative Liabilities Current | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $12.2K | |||||
| Loans Payable | $40.0K | |||||
| Repayments Of Related Party Debt | $14.8K | $43.9K | $143.5K | |||
| Property Plant And Equipment Net | $441.1K | $251.3K | ||||
| Debt Instrument Unamortized Discount Current | $15.8K | $0.00 | $182.0K | $2.9K | ||
| Writeoff Of Accounts Payable | $0.00 | $292.6K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | -$2.1M | -$1.9M | -$1.8M | -$1.8M | -$1.9M | -$2.4M | -$1.6M | -$1.7M | -$1.8M | -$1.9M | -$1.8M | -$2.9M | -$2.2M | -$1.0M | -$1.1M | -$722.0K | -$1.0M | -$1.1M | -$834.5K | -$1.2M | -$2.2M |
| Cash | $24.3K | $3.0K | $25.3K | $19.2K | $13.5K | $12.2K | |||||||||||||||
| Retained Earnings Accumulated Deficit | -$13.0M | -$12.8M | -$12.6M | -$12.6M | -$12.5M | -$12.7M | -$11.7M | -$10.9M | -$10.7M | -$6.3M | -$4.9M | -$4.9M | -$4.5M | ||||||||
| Liabilities Current | $2.2M | $2.1M | $1.9M | $1.9M | $2.0M | $2.6M | $1.9M | $1.8M | $1.8M | $3.0M | $1.8M | $1.7M | $1.3M | ||||||||
| Liabilities And Stockholders Equity | $140.3K | $163.0K | $211.7K | $209.0K | $191.2K | $198.4K | $357.8K | $19.3K | $13.8K | $817.2K | $804.5K | $605.6K | $595.6K | ||||||||
| Liabilities | $2.3M | $2.2M | $2.0M | $2.0M | $2.1M | $2.6M | $1.9M | $1.9M | $1.9M | $3.1M | $1.8M | $1.7M | $1.3M | ||||||||
| Common Stock Value | $464.0K | $454.8K | $454.8K | $442.3K | $424.4K | $397.2K | $385.2K | $355.1K | $348.2K | $91.1K | $75.7K | $75.6K | $74.7K | ||||||||
| Assets | $140.3K | $163.0K | $211.7K | $209.0K | $191.2K | $198.4K | $357.8K | $19.3K | $13.8K | $817.2K | $804.5K | $605.6K | $595.6K | ||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $48.3K | $79.2K | $81.6K | $93.8K | $12.6K | -$28.3K | -$10.8K | -$31.7K | -$18.5K | $49.9K | $67.0K | $35.4K | $41.7K | ||||||||
| Accounts Payable And Accrued Liabilities Current | $837.4K | $799.6K | $783.2K | $724.9K | $731.3K | $721.2K | $699.5K | $624.5K | $578.5K | $558.7K | $549.4K | $886.0K | $850.1K | ||||||||
| Minority Interest | -$46.7K | -$46.7K | -$46.7K | -$46.7K | -$46.7K | -$46.7K | $46.7K | -$46.6K | -$46.6K | -$1.4K | -$1.4K | -$1.3K | -$1.2K | ||||||||
| Convertible Notes Payable Current | $150.6K | $173.9K | $176.0K | $120.0K | $210.0K | $206.6K | $190.8K | $190.8K | $190.8K | $57.9K | $134.7K | $145.9K | |||||||||
| Convertible Long Term Notes Payable | $11.8K | $9.6K | $6.4K | $5.2K | $2.9K | $2.4K | $2.0K | $1.3K | |||||||||||||
| Prepaid Expense And Other Assets | $195.3K | $347.2K | $0.00 | $352.7K | $355.1K | $118.4K | $21.8K | ||||||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | -$11.9K | -$42.5K | -$10.9K | -$6.2K | -$2.9K | -$1.8K | -$1.2K | -$13.2K | $54.9K | ||||||||||||
| Accounts And Other Receivables Net Current | $62.00 | $88.00 | $261.00 | $790.00 | $899.00 | $1.0K | $13.3K | ||||||||||||||
| Interest And Debt Expense | $8.2K | $8.1K | $8.3K | $10.8K | $10.1K | $10.1K | $10.1K | $626.8K | |||||||||||||
| Assets Current | $51.5K | $74.1K | $209.0K | $13.8K | $266.2K | $388.0K | $393.1K | $155.0K | $47.9K | ||||||||||||
| Debt Instrument Unamortized Discount Noncurrent | $12.6K | $15.3K | $17.4K | $20.7K | $21.9K | $24.6K | $26.5K | ||||||||||||||
| Preferred Stock Value | $10.00 | $10.00 | $10.00 | $10.00 | $10.00 | $10.00 | $9.8M | $10.00 | $10.00 | ||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | -$27.0K | -$122.1K | |||||||||||||||||||
| Gain Loss On Disposition Of Intangible Assets | -$1.2M | -$122.7K | -$37.3K | ||||||||||||||||||
| Gain Loss On Sale Of Debt Investments | $0.00 | $0.00 | $0.00 | $145.5K | -$31.9K | ||||||||||||||||
| Derivative Liabilities Current | $215.6K | $172.1K | $110.4K | $271.4K | $306.6K | $472.0K | $399.7K | $1.4M | $1.8M | $678.1K | $107.5K | ||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $5.3K | $7.4K | $25.0K | $8.0K | $24.3K | $3.0K | $10.5K | $25.3K | |||||||||||||
| Loans Payable | $129.3K | $128.7K | $0.00 | $99.1K | $31.0K | $40.0K | $31.6K | $31.5K | |||||||||||||
| Repayments Of Related Party Debt | $2.6K | $6.0K | |||||||||||||||||||
| Property Plant And Equipment Net | $429.2K | $411.4K | $450.6K | $547.7K | |||||||||||||||||
| Debt Instrument Unamortized Discount Current | $0.00 | $459.0K | $566.2K | ||||||||||||||||||
| Writeoff Of Accounts Payable | $0.00 | $0.00 | $292.6K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Effect Of Exchange Rate On Cash And Cash Equivalents | $11.6K | -$9.1K | -$101.9K | ||
| Net Cash Provided By Used In Operating Activities | -$426.6K | -$206.1K | -$607.6K | -$317.8K | -$785.5K |
| Net Cash Provided By Used In Financing Activities | $313.7K | $257.5K | $562.6K | $432.8K | $1.1M |
| Increase Decrease In Due To Related Parties | $30.4K | $106.4K | $80.7K | $4.7K | -$23.1K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $65.4K | $147.7K | -$85.8K | $231.1K | $18.4K |
| Increase Decrease In Prepaid Expense | -$146.9K | $343.7K | -$137.9K | -$101.4K | -$3.5K |
| Increase Decrease In Accounts And Other Receivables | $5.00 | $10.3K | $21.1K | -$28.6K | |
| Proceeds From Issuance Of Common Stock | $570.1K | $75.0K | $298.2K | ||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $95.6K | -$38.3K | -$5.5K | ||
| Proceeds From Related Party Debt | $96.1K | $247.5K | |||
| Net Cash Provided By Used In Investing Activities | -$196.1K | -$251.3K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2022 | Q4 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q2 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Effect Of Exchange Rate On Cash And Cash Equivalents | -$13.2K | $12.7K | $42.5K | -$17.1K | -$31.5K | $12.4K | $49.7K | -$31.5K | $12.4K | -$15.8K | |||
| Net Cash Provided By Used In Operating Activities | -$19.5K | -$148.5K | -$71.9K | -$270.6K | |||||||||
| Net Cash Provided By Used In Financing Activities | $47.4K | $136.0K | $68.1K | $60.8K | |||||||||
| Increase Decrease In Due To Related Parties | $25.9K | $24.7K | $5.3K | -$60.6K | |||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $53.3K | $40.0K | $30.3K | $1.7K | |||||||||
| Increase Decrease In Prepaid Expense | -$5.1K | ||||||||||||
| Increase Decrease In Accounts And Other Receivables | $9.6K | -$1.2K | |||||||||||
| Proceeds From Issuance Of Common Stock | $0.00 | $92.0K | $121.5K | $134.8K | |||||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | -$11.0K | -$2.3K | |||||||||||
| Proceeds From Related Party Debt | $0.00 | $50.0K | |||||||||||
| Net Cash Provided By Used In Investing Activities | -$11.1K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Diluted EPS * | -$0.02 | -$0.03 | -$0.01 | -$0.04 | |
| Weighted Average Number Of Shares Outstanding Basic | 403.7M | 293.7M | 82.1M | 74.1M | 24.8M |
| Common Stock Shares Authorized | 2.00B | 500.0M | 9.00B | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | ||
| Common Stock Shares Outstanding | 381.2M | 95.8M | 75.6M | 71.6M | |
| Common Stock Shares Issued | 381.2M | 95.8M | 75.6M | 71.6M | |
| Preferred Stock Shares Authorized | 1.0M | ||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | ||||
| Preferred Stock Shares Outstanding | 10.0K | 0.00 | |||
| Preferred Stock Shares Issued | 10.0K | 0.00 | |||
| Earnings Per Share Basic |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q2 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $0.00 | $0.00 | -$0.01 | -$0.02 | -$0.01 | -$0.01 | |||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 406.6M | 394.4M | 351.8M | 307.0M | 82.9M | 75.7M | 75.6M | 74.7M | 74.3M | 72.2M | 34.6M | ||||||
| Common Stock Shares Authorized | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B | 500.0M | 500.0M | 500.0M | 500.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Outstanding | 464.0M | 454.8M | 454.8M | 442.3M | 424.4M | 397.2M | 385.2M | 355.1M | 348.2M | 91.1M | 75.7M | 75.6M | 74.7M | ||||
| Common Stock Shares Issued | 464.0M | 454.8M | 454.8M | 442.3M | 424.4M | 397.2M | 385.2M | 355.1M | 348.2M | 91.1M | 75.7M | 75.6M | 74.7M | ||||
| Preferred Stock Shares Authorized | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | |||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Preferred Stock Shares Outstanding | 10.0K | 10.0K | 10.0K | 10.0K | 10.0K | 10.0K | 10.0K | 10.0K | 10.0K | ||||||||
| Preferred Stock Shares Issued | 10.0K | 10.0K | 10.0K | 10.0K | 10.0K | 10.0K | 10.0K | 10.0K | 10.0K | ||||||||
| Earnings Per Share Basic | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Salaries And Wages | $16.5K | $19.4K | $17.4K | $17.9K | $17.2K |
| Professional Fees | $63.1K | $127.4K | $179.0K | $81.1K | $124.0K |
| Stock Issued During Period Value Conversion Of Units | $4.9M | $343.9K | $390.00 | $3.2K | |
| Consulting Fees | $924.6K | $526.5K | $224.7K | $442.5K | $251.8K |
| Additional Paid In Capital | $9.7M | $4.0M | $3.8M | $2.5M | |
| Stock Issued During Period Value Issued For Services | $461.0K | $627.7K | $10.8K | $294.1K | |
| Due To Related Parties Current | $605.0K | $508.9K | $475.7K | $282.9K | |
| Gain Loss On Sale Of Derivatives | $215.6K | -$3.3M | -$1.1M | ||
| Accretion Of Discount On Convertible Notes | $18.5K | $88.3K | $328.3K | -$1.3K | |
| Legal Fees | $0.00 | $893.00 | $3.8K | $207.8K | |
| Foreign Exchange Loss | $8.00 | -$6.1K | $78.9K | ||
| Foreign Currency Translation Loss | $102.1K | -$45.1K | -$11.6K | ||
| Stock Issued During Period Value New Issues | $187.0K | $267.7K | $40.0K | ||
| Interest Paid Net | $0.00 | $0.00 | $4.6K | ||
| Foreign Currency Transaction Gain Loss Before Tax | -$102.1K | -$45.1K | $11.6K | ||
| Foreign Exchange Loss Gain | $31.7K | -$8.7K | $8.00 | ||
| Income Loss Attributable To Parent | -$875.5K | -$4.5M | -$2.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q2 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Salaries And Wages | $1.9K | $1.8K | $1.8K | $4.3K | $5.1K | $4.9K | $5.1K | $5.0K | $3.9K | $4.5K | $4.6K | $4.5K | $4.6K | $4.2K | $4.6K | ||
| Professional Fees | $12.0K | $7.9K | $24.5K | $10.2K | $12.1K | $31.5K | $18.8K | $59.5K | $40.1K | $24.2K | $25.6K | $15.1K | $19.8K | $43.6K | $57.0K | ||
| Stock Issued During Period Value Conversion Of Units | $2.9M | $1.6M | $142.3K | $21.1K | $21.1K | $200.00 | $1.3M | ||||||||||
| Consulting Fees | $139.9K | $198.1K | $424.4K | $139.5K | $190.8K | $56.1K | $30.1K | $53.1K | $70.8K | $101.6K | $46.8K | $55.5K | $66.4K | ||||
| Additional Paid In Capital | $10.3M | $10.3M | $10.3M | $10.3M | $10.1M | $10.0M | $10.00 | $8.6M | $8.6M | $3.9M | $3.8M | $3.8M | $3.7M | ||||
| Stock Issued During Period Value Issued For Services | $84.7K | $208.7K | $0.00 | $121.5K | $7.3K | $1.4K | $187.2K | ||||||||||
| Due To Related Parties Current | $90.7K | $665.3K | $90.2K | $644.6K | $712.5K | $673.7K | $607.8K | $578.8K | $425.7K | $351.0K | $419.3K | $410.2K | |||||
| Gain Loss On Sale Of Derivatives | -$66.7K | -$17.1K | $161.0K | $510.1K | -$563.9K | $234.3K | $101.4K | -$2.5M | -$1.2M | -$122.7K | |||||||
| Accretion Of Discount On Convertible Notes | $10.9K | $1.8K | -$13.2K | -$54.9K | -$16.4K | -$6.6K | -$241.00 | -$298.00 | -$361.00 | ||||||||
| Legal Fees | $190.8K | $30.1K | -$7.00 | $909.00 | $1.5K | -$7.00 | $1.9K | $152.9K | |||||||||
| Foreign Exchange Loss | -$2.8K | -$15.8K | $31.6K | -$9.7K | -$45.4K | -$8.0K | $43.2K | $8.9K | |||||||||
| Foreign Currency Translation Loss | -$30.9K | -$2.4K | -$12.1K | -$17.5K | -$2.5K | -$13.2K | -$12.7K | -$42.5K | |||||||||
| Stock Issued During Period Value New Issues | $68.5K | $26.5K | $92.0K | $63.4K | $96.2K | $27.0K | |||||||||||
| Interest Paid Net | $0.00 | $0.00 | |||||||||||||||
| Foreign Currency Transaction Gain Loss Before Tax | $3.5K | $717.00 | $2.8K | $12.3K | $3.7K | -$576.00 | -$12.7K | ||||||||||
| Foreign Exchange Loss Gain | $12.3K | -$3.7K | -$3.0K | -$2.8K | -$15.8K | ||||||||||||
| Income Loss Attributable To Parent | -$39.4K | $251.9K | -$1.0M | $18.7K | -$142.1K | -$3.1M |
Most recent annual filing with the SEC: January 17, 2023
Data sourced from SEC EDGAR public filings as of August 5, 2026.